biotech
‘Pharma bro’ Shkreli heads to jail
September 14, 2017Medical Communications Martin Shkreli, Shkreli, biotech, drugs, pharma, pharmaceutical
Martin Shkreli’s habit of being unable to stay out of the headlines continues, although this time with the repercussion that …
Sanofi/Regeneron new asthma data bolstered by potential indications
September 13, 2017Research and Development Dupixent, Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi and Regeneron’s Dupixent is predicted to grow to be one of the largest selling drugs in the industry but …
23andMe raises $250m in financing, research points towards its future
September 13, 2017Research and Development, Sales and Marketing 23andME, biotech, drugs, pharma, pharmaceutical
23andMe made two announcements on the same day that point towards the future of its business: it revealed it had …
Recipharm and CTC launch integrated first in human service
September 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm, biotech, drugs, pharma, pharmaceutical
Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch …
Newly adopted flu vaccine could save 1,700 lives
September 12, 2017Research and Development, Sales and Marketing biotech, drugs, flu, fluad, pharma, pharmaceutical, seqirus
The Fluad flu vaccine, produced by Seqirus, was approved by the MHRA for use beginning in 2018 and further data …
Teva announces sale of Paragard for $1.1 billion
September 12, 2017Manufacturing and Production, Sales and Marketing Paragard, Teva, biotech, drugs, pharma, pharmaceutical
Shortly after the news that Teva had finally sealed the deal on a new CEO, it also announced that it …
Questions raised after two deaths in AbbVie arthritis study
September 12, 2017Manufacturing and Production, Research and Development AbbVie, biotech, drugs, pharma, pharmaceutical, rheumatoid arthritis
AbbVie’s rheumatoid arthritis drug, upadacitinib, is the company’s big plan to manage the inevitable loss of sales from Humira, as …
Mental health crisis as UK struggles with number of psychiatrists
September 11, 2017Business Services, Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical, psychiatry
Research undertaken by the Royal College of Psychiatrists using data from NHS Digital has found that the number of psychiatrists …
Melanoma treatment: Novartis posts success, Roche stumbles
September 11, 2017Research and Development, Sales and Marketing Novartis, Roche, biotech, drugs, melanoma, pharma, pharmaceutical
In a perfect example of the competitive nature of the pharmaceutical industry, just as one company posted success in one …
Teva finally announces successful CEO appointment
September 11, 2017Medical Communications, Sales and Marketing Lundbeck, Teva, biotech, drugs, pharma, pharmaceutical
Teva has announced that its protracted search for a new CEO has finally come to end, as it revealed the …
Casebia Therapeutics bolsters leadership by bringing in two new faces
September 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, CRISPR Therapeutics, Casebia Therapeutics, biotech, drugs, pharma, pharmaceutical
Casebia therapeutics, a joint venture between Bayer and CRISPR Therapeutics, has moved to strengthen its leadership team by bringing in …
Aspirin may be a cost-effective alternative to fillings
September 8, 2017Medical Communications, Research and Development aspirin, biotech, dentist, drugs, pharma, pharmaceutical, tooth decay
Researchers from Queen University, Belfast, have discovered that aspirin may be able to reverse the effects of tooth decay. In …
BMS’ Opdivo gets a potential first-line boost in kidney cancer
September 8, 2017Medical Communications, Research and Development Bristol-Myers Squibb, biotech, drugs, opdivo, pharma, pharmaceutical
Bristol-Myers Squibb has announced results from a Phase 3 trial showing that patients treated with Opdivo alongside Yervoy in patients …
Antidepressants polluting rivers building up in brains of fish
September 7, 2017Medical Communications antidepressants, biotech, drugs, pharma, pharmaceutical
A study of ecosystem of the Niagara River has discovered that antidepressants are building up in the brains of fish. …
Vertex Pharma bring in new CFO, shares rise
September 7, 2017Ironwood Pharmaceuticals, Vertex pharmaceuticals, biotech, drugs, pharma, pharmaceutical
Vertex Pharmaceuticals announced the appointment of J&J veteran, Tom Graney, as Senior Vice President and Chief Financial Officer. Graney will …
